ZA201208616B - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations - Google Patents
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinationsInfo
- Publication number
- ZA201208616B ZA201208616B ZA2012/08616A ZA201208616A ZA201208616B ZA 201208616 B ZA201208616 B ZA 201208616B ZA 2012/08616 A ZA2012/08616 A ZA 2012/08616A ZA 201208616 A ZA201208616 A ZA 201208616A ZA 201208616 B ZA201208616 B ZA 201208616B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydroimidazo
- quinazoline
- substituted
- containing combinations
- combinations
- Prior art date
Links
- NTTQCLSBWRKUIJ-UHFFFAOYSA-N 2,3-dihydroimidazo[1,2-c]quinazoline Chemical class C1=CC=C2C3=NCCN3C=NC2=C1 NTTQCLSBWRKUIJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10160109 | 2010-04-16 | ||
| PCT/EP2011/055917 WO2011128407A2 (en) | 2010-04-16 | 2011-04-14 | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201208616B true ZA201208616B (en) | 2015-08-26 |
Family
ID=44144895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/08616A ZA201208616B (en) | 2010-04-16 | 2012-11-15 | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
Country Status (24)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2168583A1 (en) | 2008-09-24 | 2010-03-31 | Bayer Schering Pharma Aktiengesellschaft | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma |
| UA113280C2 (xx) | 2010-11-11 | 2017-01-10 | АМІНОСПИРТЗАМІЩЕНІ ПОХІДНІ 2,3-ДИГІДРОІМІДАЗО$1,2-c]ХІНАЗОЛІНУ, ПРИДАТНІ ДЛЯ ЛІКУВАННЯ ГІПЕРПРОЛІФЕРАТИВНИХ ПОРУШЕНЬ І ЗАХВОРЮВАНЬ, ПОВ'ЯЗАНИХ З АНГІОГЕНЕЗОМ | |
| JO3733B1 (ar) * | 2011-04-05 | 2021-01-31 | Bayer Ip Gmbh | استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة |
| EP2508525A1 (en) | 2011-04-05 | 2012-10-10 | Bayer Pharma Aktiengesellschaft | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts |
| WO2014160034A1 (en) * | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Aldehyde dehydrogenase-1 modulators and methods of use thereof |
| EA031493B9 (ru) | 2013-04-08 | 2019-12-18 | Байер Фарма Акциенгезельшафт | Комбинация и фармацевтическая композиция для лечения или профилактики неходжкинской лимфомы (нхл) |
| WO2015082376A2 (en) * | 2013-12-03 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Use of pi3k-inhibitors |
| KR20180013851A (ko) * | 2015-03-09 | 2018-02-07 | 바이엘 파마 악티엔게젤샤프트 | 치환된 2,3-디히드로이미다조[1,2-c]퀴나졸린-함유 조합물 |
| EA201791975A1 (ru) * | 2015-03-09 | 2018-03-30 | Байер Фарма Акциенгезельшафт | ПРИМЕНЕНИЕ ЗАМЕЩЕННЫХ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНОВ |
| WO2017153220A1 (en) * | 2016-03-08 | 2017-09-14 | Bayer Pharma Aktiengesellschaft | 2—amino—n— [7—methoxy—2, 3-dihydroimidazo-[1, 2-c] quinazolin-5-yl] pyrimidine—5—carboxamides |
| EP3645005A1 (en) | 2017-06-28 | 2020-05-06 | Bayer Consumer Care AG | Combination of a pi3k-inhibitor with an androgen receptor antagonist |
| US11498923B2 (en) | 2017-12-13 | 2022-11-15 | Merck Sharp & Dohme Llc | Substituted imidazo[1,2-c]quinazolines as A2A antagonists |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US7511041B2 (en) * | 2002-09-30 | 2009-03-31 | Bayer Pharmaceuticals Corporation | Fused azole-pyrimidine derivatives |
| JP4323793B2 (ja) | 2002-12-16 | 2009-09-02 | キヤノン株式会社 | ズームレンズ及びそれを有する光学機器 |
| DE102004037875B4 (de) | 2004-08-04 | 2008-05-08 | Siemens Ag | Sensorvorrichtung, Verfahren und Vorrichtung zum Überwachen einer Sensorvorrichtung |
| US8101799B2 (en) * | 2005-07-21 | 2012-01-24 | Ardea Biosciences | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK |
| CA2618218C (en) * | 2005-07-21 | 2015-06-30 | Ardea Biosciences, Inc. | N-(arylamino)-sulfonamide inhibitors of mek |
| AR064106A1 (es) * | 2006-12-05 | 2009-03-11 | Bayer Schering Pharma Ag | Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis |
| EP2291350A4 (en) * | 2008-04-14 | 2012-09-19 | Ardea Biosciences Inc | COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE AND USE |
| EP2168583A1 (en) * | 2008-09-24 | 2010-03-31 | Bayer Schering Pharma Aktiengesellschaft | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma |
-
2011
- 2011-04-14 US US13/640,994 patent/US20130184270A1/en not_active Abandoned
- 2011-04-14 JP JP2013504278A patent/JP5886271B2/ja not_active Expired - Fee Related
- 2011-04-14 PE PE2012002028A patent/PE20130191A1/es not_active Application Discontinuation
- 2011-04-14 CN CN201180029827.XA patent/CN102958540B/zh not_active Expired - Fee Related
- 2011-04-14 MX MX2012012064A patent/MX2012012064A/es unknown
- 2011-04-14 PH PH1/2012/502069A patent/PH12012502069A1/en unknown
- 2011-04-14 KR KR1020127029890A patent/KR20130098155A/ko not_active Withdrawn
- 2011-04-14 EA EA201201414A patent/EA201201414A8/ru unknown
- 2011-04-14 BR BR112012026480A patent/BR112012026480A2/pt not_active IP Right Cessation
- 2011-04-14 CA CA2796253A patent/CA2796253A1/en not_active Abandoned
- 2011-04-14 MA MA35308A patent/MA34158B1/fr unknown
- 2011-04-14 WO PCT/EP2011/055917 patent/WO2011128407A2/en not_active Ceased
- 2011-04-14 SG SG2012075511A patent/SG184550A1/en unknown
- 2011-04-14 EP EP11714553A patent/EP2558126A2/en not_active Withdrawn
- 2011-04-14 AU AU2011240003A patent/AU2011240003A1/en not_active Abandoned
-
2012
- 2012-10-11 IL IL222356A patent/IL222356A0/en unknown
- 2012-10-12 TN TNP2012000493A patent/TN2012000493A1/en unknown
- 2012-10-15 EC ECSP12012261 patent/ECSP12012261A/es unknown
- 2012-10-16 CU CU2012000150A patent/CU20120150A7/es unknown
- 2012-10-16 CL CL2012002887A patent/CL2012002887A1/es unknown
- 2012-10-16 CO CO12182241A patent/CO6620036A2/es not_active Application Discontinuation
- 2012-10-16 DO DO2012000269A patent/DOP2012000269A/es unknown
- 2012-10-16 CR CR20120524A patent/CR20120524A/es unknown
- 2012-11-15 ZA ZA2012/08616A patent/ZA201208616B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2012002887A1 (es) | 2013-01-18 |
| PH12012502069A1 (en) | 2013-02-04 |
| MX2012012064A (es) | 2012-12-17 |
| TN2012000493A1 (en) | 2014-04-01 |
| CO6620036A2 (es) | 2013-02-15 |
| US20130184270A1 (en) | 2013-07-18 |
| EP2558126A2 (en) | 2013-02-20 |
| CU20120150A7 (es) | 2013-02-26 |
| EA201201414A1 (ru) | 2013-04-30 |
| WO2011128407A2 (en) | 2011-10-20 |
| CR20120524A (es) | 2013-01-09 |
| KR20130098155A (ko) | 2013-09-04 |
| SG184550A1 (en) | 2012-11-29 |
| WO2011128407A9 (en) | 2011-12-22 |
| JP5886271B2 (ja) | 2016-03-16 |
| WO2011128407A3 (en) | 2012-02-23 |
| JP2013525293A (ja) | 2013-06-20 |
| CA2796253A1 (en) | 2011-10-20 |
| IL222356A0 (en) | 2012-12-31 |
| HK1182937A1 (en) | 2013-12-13 |
| PE20130191A1 (es) | 2013-02-21 |
| MA34158B1 (fr) | 2013-04-03 |
| BR112012026480A2 (pt) | 2016-08-16 |
| ECSP12012261A (es) | 2012-11-30 |
| DOP2012000269A (es) | 2012-12-15 |
| AU2011240003A1 (en) | 2012-11-08 |
| EA201201414A8 (ru) | 2013-12-30 |
| CN102958540A (zh) | 2013-03-06 |
| CN102958540B (zh) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3709A (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts | |
| ZA201208616B (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | |
| SG11201401342VA (en) | 5,7-substituted-imidazo[1,2-c]pyrimidines | |
| AP2013007147A0 (en) | Use of substituted 2,3-dihydroimidazo[1,2-C]quinyzolines | |
| EP2619203A4 (en) | TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | |
| ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| SI2507235T1 (sl) | Triazolopirimidini | |
| ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
| IL229993A (en) | 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2 | |
| AU334279S (en) | Toy block | |
| EP2581371A4 (en) | PYRROLYL-SUBSTITUTED DIHYDROINDOL-2-ON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF | |
| AU334278S (en) | Toy block | |
| IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
| PL2572696T3 (pl) | Inteligentna apteczka pierwszej pomocy | |
| ZA201302112B (en) | 1,4-oxazepane derivatives | |
| PL2469107T3 (pl) | Tuleja ślizgowa | |
| TWI561274B (en) | The pacemaker | |
| HK1196363A (en) | 5,7-substituted-imidazo[1,2-c]pyrimidines | |
| AU2010901109A0 (en) | Adjustable, multi-purpose plus | |
| GB201020160D0 (en) | The club | |
| HK1176060A (en) | Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors | |
| AU2010904564A0 (en) | Build ball | |
| AU2010903003A0 (en) | Sequenced vaso-stimulii therapy | |
| GB201019374D0 (en) | Pet-waste kit |